| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/22/2004 | EP1459759A1 Drug mobilizing pluripotent stem cells from tissue into peripheral blood |
| 09/22/2004 | EP1459758A1 Agents promoting the proliferation and/or differentiation of hematopoietic stem cells and/or hematopoietic precursor cells |
| 09/22/2004 | EP1459738A1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties |
| 09/22/2004 | EP1458866A2 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 09/22/2004 | EP1458854A2 Cellular compositions and methods of making and using them |
| 09/22/2004 | EP1458759A2 Human antibodies against human glycoprotein vi and their use |
| 09/22/2004 | EP1458757A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 09/22/2004 | EP1458754A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 09/22/2004 | EP1458746A2 Cyclic tetrapeptide compound and use thereof |
| 09/22/2004 | EP1458723A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/22/2004 | EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 09/22/2004 | EP1458721A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino 4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 09/22/2004 | EP1458718A1 Quinolinones as prostaglandin receptor ligands |
| 09/22/2004 | EP1458717A1 Aroyl pyridinones |
| 09/22/2004 | EP1458712A2 Novel compounds |
| 09/22/2004 | EP1458691A2 Benzodiazepine derivatives, preparation thereof and use thereof |
| 09/22/2004 | EP1458690A1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 09/22/2004 | EP1458679A2 Pyrrolidine derivatives as prostaglandin modulators |
| 09/22/2004 | EP1458425A2 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis |
| 09/22/2004 | EP1458408A1 Liquid composition of factor vii polypeptides |
| 09/22/2004 | EP1458407A1 Liquid composition of modified factor vii polypeptides |
| 09/22/2004 | EP1458397A1 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure |
| 09/22/2004 | EP1458392A2 Acridone inhibitors of impdh enzyme |
| 09/22/2004 | EP1458389A1 Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion |
| 09/22/2004 | EP1458352A1 Solid dose micro implant |
| 09/22/2004 | EP1153014B1 Beta-alanine derivatives |
| 09/22/2004 | EP1146874B1 Vitronectin receptor antagonist |
| 09/22/2004 | EP1040112B1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 09/22/2004 | EP1012164B1 Serine protease inhibitors |
| 09/22/2004 | EP1000062B1 Tricyclic vasopressin agonists |
| 09/22/2004 | EP0737207B1 Inhibitors of human plasmin derived from the kunitz domains |
| 09/22/2004 | EP0623133B1 Substituted amino alkyl compounds |
| 09/22/2004 | CN1531653A Method for identification of proteins from intracellular bacteria |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531555A Glycosaminoglycans derived from K5 polysaccharide having high antithrombin activity and process for their preparation |
| 09/22/2004 | CN1531554A Humanized antibodies derived from DD-3B6-22, specific for D-dimer fragment of fibrin |
| 09/22/2004 | CN1531529A 4-(benzylidenje-amino)-3-(methylsulfanyl)-4H-(1,2,4) triazin-5-one derivatives having PDE-IV inhibiting and TNF-antagonistic effect for treatment of cardiac diseases and allergies |
| 09/22/2004 | CN1531441A Pharmaceutical compositinos which inhibit vascular proliferation and method of use thereof |
| 09/22/2004 | CN1531436A Formulation of amphiphilic heparin derivatives for enhancing mucosal absorption |
| 09/22/2004 | CN1531425A Urea derivatives as integrin alpha 4 antagonists |
| 09/22/2004 | CN1530368A Synthesis of sulfated alpha (1->3) linked L-fucose |
| 09/22/2004 | CN1530129A Health care Husheng capsules for human blood health |
| 09/22/2004 | CN1530122A Chinese medicine for treating injury |
| 09/22/2004 | CN1530102A Medical preparation containing alpha-thioctan, ambroxol and/or ACE inhibiting agent and its use in treating neurodegenerative diseases |
| 09/22/2004 | CN1530101A Healthy food composition for purifying blood, improving immunity and regulating blood fat |
| 09/22/2004 | CN1167712C Interleukin 11 analog |
| 09/22/2004 | CN1167709C N-pyrazole AZA receptor agonists |
| 09/22/2004 | CN1167681C Condensed indoline derivatives and their use as 5HT, in particular 5HT2 receptor ligands |
| 09/22/2004 | CN1167670C Aryl carboxylic acid and tetrazole derivant |
| 09/22/2004 | CN1167667C Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
| 09/22/2004 | CN1167467C Antiswelling medicine |
| 09/22/2004 | CN1167456C Compound paste of donkey-skin gelatin for enriching blood |
| 09/21/2004 | US6794515 Synthesis of 2-alkylcysteine via substituted thiazoline amide |
| 09/21/2004 | US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease |
| 09/21/2004 | US6794507 Compounds that inhibit factor Xa activity |
| 09/21/2004 | US6794403 Substituted benzoxazoles as estrogenic agents |
| 09/21/2004 | US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794382 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 09/21/2004 | US6794380 Amide derivatives |
| 09/21/2004 | US6794375 Palatable arginine compounds and uses thereof for cardiovascular health |
| 09/21/2004 | US6794365 Inhibitors of the blood clotting enzyme factor xa; treating thromboembolic diseases; trifluoroacetic acid salt of 2-(4-carbamimidoyl-benzyl)-n-((1-carbamoyl-4-guanidino-butylcarbamoyl) -cyclohexyl-methyl)-n',n'-dimethyl-malonamide |
| 09/21/2004 | US6794166 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/21/2004 | US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells |
| 09/21/2004 | CA2167673C Condensed benzazepine derivative and pharmaceutical composition thereof |
| 09/21/2004 | CA2155843C Novel urea derivatives, their preparation and use |
| 09/21/2004 | CA2146757C Stabilization of fluorocarbon emulsions |
| 09/16/2004 | WO2004078719A1 Indole derivative compounds and drugs containing the compounds as the active ingredient |
| 09/16/2004 | WO2003070746A3 Purification and characterization of a prothrombin activator from the bristled of lonomia obliqua |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | WO2003045228A9 Methods for treating autoimmune disorders, and reagents related thereto |
| 09/16/2004 | WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/16/2004 | US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040181035 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 09/16/2004 | US20040181032 for promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 09/16/2004 | US20040180962 Dosage forms having prolonged active ingredient release |
| 09/16/2004 | US20040180938 More preferred compound is (1Z,3E)-1-methyl-1-(4-carboxyphenyl)-2-methoxycarbonyl-3-(2-methylpyridin-4-yl)aminocarbonyl-4-(3-methoxyphenyl)butadiene; for the treatment of acute coronary symptoms |
| 09/16/2004 | US20040180890 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/16/2004 | US20040180887 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/16/2004 | US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/16/2004 | US20040180850 Polysaccharides with Helicobacter pylori receptor activity; preventing bacteria adhesion; stabilizing gastrointestinal mucus layer against ulcer causing agents |
| 09/16/2004 | US20040180837 Porphyrin compound, albumin inclusion compound thereof and artificial oxygen carrier |
| 09/16/2004 | US20040180100 Active ingredients preparation and single compound purification from traditional chinese herbal medicine fructus Trichosanthis and uses thereof |
| 09/16/2004 | US20040180051 Comprising an antibody against human tissue factor (human TF), for therapy of pulmonary thrombosis or deep venous thrombosis |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1456670A2 Methods relating to treatment of atherosclerosis |
| 09/15/2004 | EP1456419A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 09/15/2004 | EP1456403A2 Methods of using 48149, a human aminopeptidase family member |
| 09/15/2004 | EP1456402A2 Means for treatment of atherosclerosis |
| 09/15/2004 | EP1456360A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs |
| 09/15/2004 | EP1456235A2 Factor viii c2 domain variants |
| 09/15/2004 | EP1456219A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 09/15/2004 | EP1456212A1 6-aminomorphinane derivatives, method for the production and use thereof |
| 09/15/2004 | EP1456207A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 09/15/2004 | EP1456205A1 Imidazoquinoline derivatives |
| 09/15/2004 | EP1456199A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer |
| 09/15/2004 | EP1456188A1 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 09/15/2004 | EP1456175A1 Substituted heterocyclic carboxamides with antithrombotic activity |
| 09/15/2004 | EP1456172A1 Pyrrolidine-2-ones as factor xa inhibitors |